Novoprotein Scientific Inc. (SHA:688137)
42.19
+1.57 (3.87%)
At close: Mar 6, 2026
Novoprotein Scientific Market Cap
Novoprotein Scientific has a market cap or net worth of 2.94 billion as of March 6, 2026. Its market cap has increased by 28.45% in one year.
Market Cap
2.94B
Enterprise Value
2.19B
Revenue
151.51M
Ranking
n/a
PE Ratio
n/a
Stock Price
42.19
Market Cap Chart
Since September 29, 2022, Novoprotein Scientific's market cap has decreased from 5.30B to 2.94B, a decrease of -44.45%. That is a compound annual growth rate of -15.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 2.94B | 5.34% |
| Dec 31, 2025 | 2.79B | 20.54% |
| Dec 31, 2024 | 2.32B | -40.46% |
| Dec 29, 2023 | 3.89B | -27.00% |
| Dec 30, 2022 | 5.33B | 0.65% |
| Sep 29, 2022 | 5.30B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Guangdong VTR Bio-Tech | 3.12B |
| Shanghai Hile Bio-Technology | 3.07B |
| Cabio Biotech (Wuhan) | 3.06B |
| Suzhou Fushilai Pharmaceutical | 2.94B |
| Landfar Bio-medicine | 2.87B |
| Jiangsu Sihuan Bioengineering | 2.86B |
| Jilin Jian Yisheng Pharmaceutical | 2.69B |
| Shanghai Universal Biotech | 2.68B |